John Crowley, Amicus executive chairman
October 31, 2022 06:51 AM EDT
FDA+

Am­i­cus ex­ecs get back up smil­ing af­ter be­ing scuffed again by lat­est set­back

John Carroll

Editor & Founder

Am­i­cus $FOLD is con­tin­u­ing its se­ries of painful prat­falls as the biotech re­peat­ed­ly trips its way to­ward what ex­ec­u­tive chair­man John Crow­ley con­tin­ues to see …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

A service from the Financial Times